MacroGenics (MGNX) PT Lowered to $6 at Stifel
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
MacroGenics (MGNX) PT Lowered to $5 at BMO Capital
August 7, 2024 9:23 AM EDTBMO Capital analyst Etzer Darout lowered the price target on MacroGenics (NASDAQ: MGNX) to $5.00 (from $8.00) while maintaining a Market Perform rating.
The analyst commented, "MGNX's 2Q update was in line with our expectations following the vobra duo (BH3 ADC) news last... More
Macrogenics (MGNX) Misses Q2 EPS by 23c
August 6, 2024 4:52 PM EDTMacrogenics (NASDAQ: MGNX) reported Q2 EPS of ($0.89), $0.23 worse than the analyst estimate of ($0.66). Revenue for the quarter came in at $10.79 million versus the consensus estimate of $20.94 million.
For earnings history and earnings-related data on Macrogenics (MGNX) click here.
... More